Atlas Trials

HIV

2,111 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HIV

RecordFirmDate
Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen (NCT01705873)Helios Salud2012-09-01
Secondary HIV Prevention and Adherence Among HIV-infected Drug Users (NCT01741311)University of Connecticut2012-09-01
Healthy Beginning Initiative (NCT01795261)University of Nevada, Reno2012-09-01
A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine (NCT01701882)St Stephens Aids Trust2012-09-01
Clinical Outcomes of People Who Acquired HIV in Early Life (NCT01656564)National Institute of Allergy and Infectious Diseases (NIAID)2012-08-27
Patient-Centered Disclosure Intervention for HIV-Infected Children (NCT01947764)Indiana University2012-08-01
Optimizing Clinical Outcomes in HIV-Infected Adults & Children (NCT02043080)University of North Carolina, Chapel Hill2012-08-01
Antimalarial Pharmacology in Children and Pregnant Women in Uganda (NCT01717885)University of California, San Francisco2012-08-01
Mobile Phone Text Messaging Referral (NCT01746758)Liverpool School of Tropical Medicine2012-08-01
Brazilian HIV/Sexually Transmitted Infection (STI) Prevention for Adolescents With Mental Health Disorder (NCT01854853)New York State Psychiatric Institute2012-08-01
Evaluation of Use of Clinical Decision Support System in HIV Care in Resource Constrained Settings (NCT01634802)Kenya Medical Research Institute2012-08-01
A Couple-Based Relationship Strengthening HIV Intervention for Young Parents (NCT01643005)Yale University2012-08-01
ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART (NCT01683656)Calmy Alexandra2012-08-01
ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment (NCT01671982)Institut de Recherche pour le Developpement2012-08-01
Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC (NCT01620944)Bristol-Myers Squibb2012-07-31
Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir (NCT01597180)University of North Carolina, Chapel Hill2012-07-01
Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda (NCT01579214)Massachusetts General Hospital2012-07-01
Choices-Teen: A Bundled Risk Reduction Intervention for Juvenile Justice Females (NCT02252471)University of Houston2012-07-01
Abacavir and Lamivudine PK in Children (NCT01656122)The HIV Netherlands Australia Thailand Research Collaboration2012-07-01
Enhancing Quality Interventions Promoting Healthy Sexuality (NCT01818791)RAND2012-07-01
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users (NCT01612169)Columbia University2012-07-01
Connect 'n Unite: Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM (NCT01394900)Columbia University2012-07-01
Eban II: Intervention for HIV Sero-Discordant Couples (NCT01829282)University of California, Los Angeles2012-07-01
Pilot Study of Immediate HIV Treatment in Guangxi, China (NCT01892228)National Center for AIDS/STD Control and Prevention, China CDC2012-07-01
Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone (NCT01605084)Bristol-Myers Squibb2012-06-30
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment (NCT01376570)Albert Einstein College of Medicine2012-06-01
Preliminary Evaluation of a Point-Of-Care Liver Function Test (NCT01705041)PATH2012-06-01
Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya (NCT01616420)University of Washington2012-06-01
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception (NCT01667978)University of Southern California2012-06-01
Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa (NCT02439918)Université de Sherbrooke2012-06-01
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA® (NCT01591902)Theratechnologies2012-06-01
MARCH Renal Substudy (NCT01637259)Kirby Institute2012-06-01
Thol'Impilo: Bringing People Into Care (NCT02271074)The Aurum Institute NPC2012-06-01
Kumasi Cohort Study (NCT01853657)Bernhard Nocht Institute for Tropical Medicine2012-06-01
Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz (NCT01695954)NYU Langone Health2012-05-01
Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline (NCT02086630)New York University2012-05-01
WHC+ (Women's Health CoOp PLUS) (NCT01497405)RTI International2012-05-01
Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa (NCT01715922)ANRS, Emerging Infectious Diseases2012-05-01
Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily (NCT01581853)Daniel Podzamczer2012-05-01
Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis (NCT01635153)Dartmouth-Hitchcock Medical Center2012-05-01
Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV (NCT01125696)Centers for Disease Control and Prevention2012-05-01
Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth (NCT01647841)Cornell University2012-04-01
The Role of Genital Warts in HIV Acquisition in Peru (NCT01387412)University of California, Los Angeles2012-04-01
Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique (NCT02371265)University of Washington2012-04-01
Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men (NCT01751594)University of North Carolina, Chapel Hill2012-04-01
Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events (NCT01699841)Cornell University2012-04-01
Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART) (NCT01591252)University of Alabama at Birmingham2012-04-01
Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk (NCT01510262)University of Wisconsin, Milwaukee2012-04-01
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients (NCT01645033)Yale University2012-04-01
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up (NCT01667068)University Hospital, Essen2012-04-01
Project Wellness: Increasing HIV Testing Among West African Immigrants (NCT01270061)North Bronx Healthcare Network2012-04-01
The Rilpivirine Cerebrospinal-fluid (CSF) Study (NCT01562886)Imperial College London2012-03-01
A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir (NCT01255371)ANRS, Emerging Infectious Diseases2012-03-01
Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients. (NCT01565889)Gilead Sciences2012-03-01
Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV (NCT01602822)Kenneth H. Mayer, MD2012-02-01
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study (NCT01535235)University of California, San Francisco2012-02-01
Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection (NCT02166502)The Hospital for Sick Children2012-02-01
HIV Indicator Diseases Across Europe Study (NCT01681706)Jesper Grarup2012-02-01
Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors (NCT01458977)Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia2012-01-01
Enhancing Ugandan HIV-Affected Child Development With Caregiver Training (NCT01640561)Johns Hopkins Bloomberg School of Public Health2012-01-01
Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management (NCT01510340)Centre hospitalier de l'Université de Montréal (CHUM)2012-01-01
Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test (NCT01530672)PATH2012-01-01
Increasing Availability and Acceptability of Circumcision in Zambia (NCT01688167)University of Miami2012-01-01
Knowledge Attitudes, Beliefs, and Practices Regarding HIV in Populations Living on the Maroni River (NCT02903589)Centre Hospitalier de Cayenne2012-01-01
Botswana Vitamin D Supplementation Study in HIV/AIDS (NCT02189902)Children's Hospital of Philadelphia2012-01-01
Knowledge Attitudes Behaviours and Practices Regarding HIV of Sex Workers in the French Antilles (NCT03363438)Centre Hospitalier de Cayenne2012-01-01
The Effect of Intermittent Rifampicin on Raltegravir (NCT01424826)Helen Reynolds2012-01-01
Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission (NCT01764282)National Center for AIDS/STD Control and Prevention, China CDC2012-01-01
DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects (NCT01423812)Ruth M. Rothstein CORE Center2012-01-01
Eplerenone in HIV Associated Abdominal Fat Accumulation (NCT01405456)Massachusetts General Hospital2012-01-01
The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function (NCT01475240)St Stephens Aids Trust2012-01-01
EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine (NCT01509144)PX'Therapeutics2012-01-01
Randomized Controlled Trial Using Patient Reported Outcomes and Care Managers to Improve HIV Medication Adherence in Routine Clinical Care (NCT01505660)University of Washington2012-01-01
Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi (NCT01414413)Liverpool School of Tropical Medicine2012-01-01
Knowledge Attitudes Behaviours and Practices Regarding HIV of Men Who Have Sex With Men in the French Antilles and French Guiana (NCT03359720)Centre Hospitalier de Cayenne2012-01-01
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T (NCT01543152)Sangamo Therapeutics2011-12-01
EARNEST Rifabutin Pharmacokinetics (PK) Substudy (NCT01663168)Justine Boles2011-12-01
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection (NCT01231685)McGill University Health Centre/Research Institute of the McGill University Health Centre2011-12-01
Atazanavir and Endothelial Function in Older HIV Patients (NCT03019783)Brigham and Women's Hospital2011-12-01
Project AWARE: Using the Emergency Department (ED) to Prevent Sexually Transmitted Infections (STIs) in Youth (NCT01195220)North Bronx Healthcare Network2011-12-01
Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals (NCT01293123)University of California, San Diego2011-12-01
Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations (NCT01482923)Memorial Sloan Kettering Cancer Center2011-11-22
Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients (NCT01437475)Tel-Aviv Sourasky Medical Center2011-11-01
Niacin on Immune Activation : a Proof-of-concept Study (NCT02018965)McGill University Health Centre/Research Institute of the McGill University Health Centre2011-11-01
Mfangano Island Healthy Networks Impact Study (NCT01912521)University of California, San Francisco2011-11-01
Implementation of an Efficacious Intervention for High Risk Women in Mexico (NCT01465607)University of California, San Diego2011-11-01
Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma (NCT01516593)Andres J. M. Ferreri2011-11-01
Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting (NCT01956370)Ministry of Health and Child Welfare, Zimbabwe2011-11-01
The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana (NCT01897909)Bernhard Nocht Institute for Tropical Medicine2011-11-01
Antiretroviral Drug Interaction Study in Volunteers With HIV (NCT01479361)National Institutes of Health Clinical Center (CC)2011-10-31
Levels of Raltegravir in the Female Genital Tissue (NCT01327482)University of Washington2011-10-01
The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study (NCT01348763)Imperial College London2011-10-01
A Commitment Device for Medication Adherence Among HIV Patients (NCT01455740)National Bureau of Economic Research, Inc.2011-10-01
Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women (NCT02237326)University of California, San Francisco2011-10-01
Early HIV Therapy in Patients With High CD4 Cell Counts (NCT01479634)University of California, San Francisco2011-10-01
Integrated Treatment for Smoking Cessation & Anxiety in People With HIV (NCT01393301)Massachusetts General Hospital2011-10-01
A Key Link for Transmission Prevention (NCT01450189)University of North Carolina, Chapel Hill2011-10-01
Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults (NCT01512784)University of Milan2011-10-01
Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial (NCT01841320)Johns Hopkins University2011-10-01
AIMS Study: Improving HIV Treatment Adherence (NCT01429142)Wageningen University2011-09-01
← Previous Next →

Track HIV automatically

Every clearance here is in the API, with alerts when new ones post.